Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Donepezil 10 mg orodispersible tablets vs Aricept Evess 10 mg in healthy Thai volunteers under fasting conditions
TCTR20161108001Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of donepezil in Alzheimer's disease (AD) (2 arms), sponsored by Bio-innova. Planned start Jan 2017; status: not yet recruiting.
02
Drugs
donepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on TCTR20161108001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20161108001.